Other

Pfizer 2Q net income rises 25 pct on lower costs

Drugmaker Pfizer Inc.'s second-quarter net income jumped 25 percent as sharply lower costs for production, marketing and restructuring more than offset a plunge in revenue from cholesterol fighter Lipitor due to increasing ...

Diseases, Conditions, Syndromes

More insight into Crohn's disease

Researchers Robiël Naziroglu and Frans Vos have developed a method for improving the assessment of MRI images in cases of Crohn's disease. In time, this may well enable more targeted monitoring and treatment of this chronic ...

Medications

FDA approves lower-cost alternative to biotech drug Humira

Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.

page 29 from 40